top of page
KLOW 80mg

KLOW 80mg

$95.00Price
Quantity

KLOW Protocol

KLOW is a four-peptide regenerative blend that builds on GLOW by adding KPV (a potent anti-inflammatory peptide). Like GLOW, it's marketed as an all-in-one injectable for skin and tissue regeneration — but no clinical trials have tested this specific four-peptide combination. It remains investigational with theoretical benefits based on complementary mechanisms.


Mechanism of Action

Each peptide targets different pathways:

  • GHK-CU modulates genes and stimulates collagen synthesis

  • TB-500 enhances cell migration and angiogenesis

  • BPC-157 upregulates growth factors and reduces inflammation

  • KPV potentially inhibits NF-kB (a master inflammatory switch)

In theory, stacking all four creates multi-modal tissue repair and anti-inflammatory effects. In practice, the fixed ratio may not deliver each component at its optimal therapeutic dose.

Potential Benefits

  • Comprehensive tissue regeneration from four complementary peptides

  • Enhanced anti-inflammatory effects (KPV addition over GLOW)

  • Collagen stimulation and skin remodeling (GHK-CU)

  • Wound healing and growth factor upregulation (BPC-157)

  • Cellular regeneration and angiogenesis (TB-500)

  • Potent NF-kB inhibition for systemic inflammation (KPV)

  • Single daily injection convenience

  • Potential synergistic effects across multiple aging pathways

Why It's Being Researched

Multi-peptide protocols aim to address aging and tissue damage through multiple simultaneous mechanisms rather than single-pathway approaches. KLOW specifically adds KPV — one of the most potent anti-inflammatory peptides — to the GLOW foundation.

Stacking

Compatible

  • NAD+ — different mechanisms; may complement cellular energy support during skin regeneration

  • Vitamin C — antioxidant support compatible with peptide effects

  • Retinoids — work synergistically on collagen, but start slowly; may increase skin sensitivity

Use With Caution

  • AHA/BHA exfoliants — space applications apart to avoid excessive skin irritation

  • Retinoids — monitor for cumulative irritation; introduce gradually

Avoid

  • Additional GHK-CU products — risk of copper overdose when combining with standalone copper peptide

Safety Note

Before starting KLOW, calculate individual peptide doses from your specific vial to ensure each component falls within established therapeutic ranges. If ratios are suboptimal, consider dosing BPC-157, TB-500, GHK-CU, and KPV separately.


RESEARCH PURPOSES ONLY

NOT AVAILABLE FOR HUMAN CONSUMPTION

    bottom of page